Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: EMG produced TPA metagenomics assembly of the PRJNA373901 data set (Novel gut-microbiota based metagenomic signature for advanced fibrosis in nonalcoholic fatty liver disease).

PROVIDER: PRJEB32331 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5275394.fasta.gz	Fasta.gz
	SRR5275394.bam	Bam
	SRR5275394.bam.bai	Bam
	SRR5275395.fasta.gz	Fasta.gz
	SRR5275395.bam	Bam

Items per page:

1 - 5 of 258

Similar Datasets

Project description:EMG produced TPA metagenomics assembly of PRJNA479723 data set (Nanopore metagenomics).

| PRJEB42552 | ENA

Project description:EMG produced TPA metagenomics assembly of PRJNA639280 data set (v).

| PRJEB72785 | ENA

Project description:EMG produced TPA metagenomics assembly of PRJNA986291 data set (CForBio.metagenome).

| PRJEB71756 | ENA

Project description:EMG produced TPA metagenomics assembly of PRJEB30246 data set (Metagenomic_analysis_nasopharyngeal_colonisation).

| PRJEB75197 | ENA

Project description:EMG produced TPA metagenomics assembly of PRJNA763981 data set (SOYBEAN RHIZOSPHERE METAGENOMICS).

| PRJEB54995 | ENA

Project description:EMG produced TPA metagenomics assembly of PRJEB25419 data set (Breast Cancer Metagenomics).

| PRJEB51311 | ENA

Project description:EMG produced TPA metagenomics assembly of PRJEB28161 data set (TNBS mice metagenomics).

| PRJEB60944 | ENA

Expression data for Nonalcoholic fatty liver disease patients

Project description:Nonalcoholic fatty liver disease represents a spectrum of pathology that ranges from benign steatosis to potentially-progressive steatohepatitis and affects more than 30% of US adults. Advanced NAFLD is associated with increased morbidity and mortality from cirrhosis, primary liver cancer, cardiovascular disease and extrahepatic cancers. Accurate identification of patients at risk for advanced NAFLD is challenging. The aims of this study were to define the liver gene expression patterns that distinguish mild from advanced NAFLD and to develop a gene expression profile associated with advanced NAFLD. We analyzed total RNA from 72 patients with NAFLD (40 with mild NAFLD, fibrosis stage 0-1 and 32 with advanced NAFLD, fibrosis stage 3-4) and developed a gene profile associated with advanced NAFLD. This dataset is part of the TransQST collection.

2013-08-30 | E-GEOD-49541 | biostudies-arrayexpress

microbiome

Project description:Novel gut-microbiota based metagenomic signature for advanced fibrosis in nonalcoholic fatty liver disease

| PRJNA373901 | ENA

Transcriptome profiling of human non-alcoholic fatty liver disease

Project description:Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Nonalcoholic steatohepatitis (NASH), the progressive form of NAFLD, and advanced fibrosis are associated with poor outcomes but their molecular pathogenesis is not fully elucidated. Global RNA sequencing of snap frozen liver tissue from 98 patients with biopsy-proven NAFLD was performed. Unsupervised hierarchical clustering well-distinguished NASH from NAFL, and NASH patients exhibited molecular abnormalities reflecting their pathological features. Transcriptomic analysis identified multiple secreted proteins upregulated in NASH and/or advanced fibrosis

2021-05-31 | GSE167523 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data